Due to an increase in recent call volume, wait times for inbound calls have been longer than usual.
Our members are very important to us as are their questions and inquiries.
We will get to your call as soon as we can; please email [email protected] at any time for additional assistance.

Explanation of terms

+, combined with” the vaccine that follows;
±, with or without” the vaccine(s) that follow;
CAe, cellular antigen extract (Bordetella bronchiseptica); 
CAV2, canine adenovirus-2; 
CCV, canine coronavirus; 
CDV, canine distemper virus; 
CIV, canine influenza virus; 
CPiV, canine parainfluenza virus; 
CPV, canine parvovirus; 
CPV-2b and CPV-2c, field variants of canine parvovirus recognized in the United States today; 
DOI, duration of immunity; 
FAVN, fluorescent antibody virus neutralization (rabies); 
RVNA, rabies virus neutralizing antibody ; 
IM, intramuscular;
IN, intranasal; 
Killed,
inactivated; 
MDA, maternally derived antibody; 
MLV, modified-live virus, or attenuated; 
oral, specifically administered into the buccal pouch (Bordetella bronchiseptica);
OspA,
outer surface protein A (Borellia burgdorferi);
OspC,
outer surface protein C (Borellia burgdorferi); 
rCD, recombinant canine distemper virus;
SQ,
subcutaneous.

These guidelines are supported by a generous educational grant from
Boehringer Ingelheim USA Inc., Merck Animal Health, and Zoetis.